2025-08-03 - Analysis Report
Okay, here's a report summarizing the provided information on TG Therapeutics Inc (TGTX), along with an analysis:

## TG Therapeutics Inc (TGTX) Analysis

**Company Overview:** TG Therapeutics Inc is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.

### 1. Performance vs. S&P 500 (VOO)

*   **TGTX Cumulative Return:** 67.06%
*   **VOO Cumulative Return:** 94.15%
*   **Absolute Divergence:** -14.8%
*   **Relative Divergence:** 14.3% (TGTX is in the lower range of its historical performance relative to VOO)

**Analysis of Alpha, Beta, CAGR, MDD:**

| Year       | CAGR    | MDD   | Alpha    | Beta   | Cap(B) |
|------------|---------|-------|----------|--------|--------|
| 2015-2017  | -2.0%   | 2.0%  | -31.0%   | -11.8  | 1.3    |
| 2016-2018  | -54.0%  | 58.7% | -72.0%   | 0.1    | 0.7    |
| 2017-2019  | 32.0%   | 58.7% | 3.0%     | -0.3   | 1.8    |
| 2018-2020  | 424.0%  | 58.7% | 404.0%   | 0.3    | 8.3    |
| 2019-2021  | 132.0%  | 63.5% | 84.0%    | 0.4    | 3.0    |
| 2020-2022  | -84.0%  | 70.4% | -87.0%   | 0.4    | 1.9    |
| 2021-2023  | -380.0% | 70.4% | -398.0%  | -0.9   | 2.7    |
| 2022-2024  | 72.0%   | 73.1% | 46.0%    | -1.1   | 4.8    |
| 2023-2025  | 68.0%   | 73.1% | 22.0%    | 0.0    | 5.6    |

**Analysis:**

*   **Underperformance:** TGTX has underperformed the S&P 500, with a negative divergence of -14.8%.  The relative divergence indicates TGTX is at the lower end of its historical performance range compared to the index.
*   **Alpha/Beta:** Alpha is a measure of the excess return of an investment relative to the market. A negative alpha implies that the investment has underperformed the market. Beta is a measure of an investment's volatility relative to the market. A beta greater than 1 indicates that the investment is more volatile than the market, while a beta less than 1 indicates that the investment is less volatile than the market.
*   **Volatility:** The company has experienced periods of high volatility, as evidenced by the MDD (Maximum Drawdown) figures.  The Beta values are mostly low.
*   **Growth:** The CAGR (Compound Annual Growth Rate) varies significantly, indicating periods of rapid growth and significant decline.

### 2. Recent Stock Price Movements

*   **Current Price:** $35.02
*   **Previous Close:** $35.50
*   **Change:** -1.35%
*   **5-Day Moving Average:** $35.62
*   **20-Day Moving Average:** $37.16
*   **60-Day Moving Average:** $36.36

**Analysis:**

*   **Short-Term Downtrend:** The current price is below the 5-day, 20-day, and 60-day moving averages, suggesting a short-term downtrend.
*   **Recent Drop:** The 1.35% decrease from the previous close signals downward pressure.

### 3. Market Risk Indicators and Expected Return

*   **Market Risk Indicator (MRI):** 0.3358 (Low Risk)
*   **RSI:** 29.34 (Oversold)
*   **PPO:** -0.84
*   **Hybrid Signal:** Cash 66%, Sell 5.6% of holdings
*   **Recent Relative Divergence Change (20-day):** -0.1 (Short-term decline)
*   **Expected Return:** -170.7% (Long-term relative underperformance)

**Analysis:**

*   **Low Risk (MRI):** The MRI indicates a relatively low level of overall market risk associated with TGTX.
*   **Oversold (RSI):** The RSI suggests the stock may be oversold and could experience a potential bounce.
*   **Divergence Change:** The recent negative change in relative divergence confirms the short-term downtrend.
*   **Very Negative Expected Return:** The deeply negative expected return is a significant warning sign, suggesting analysts anticipate considerable underperformance compared to the S&P 500 over the long term.
*   **Hybrid Signal:** Indicates a cautious stance, recommending a high cash position and slight selling pressure.

### 4. Recent News & Significant Events

*   **Aug 03, 2025:** Major business developments, regulatory changes, or market events.
*   **Jul 31, 2025:** Analysts discussing performance and outlook in the context of industry trends.
*   **Aug 01, 2025:** Notable stock volatility influenced by recent news and events.
*   **Aug 02, 2025:** Market experts highlight both risks and opportunities, advising monitoring of news.

**Analysis:**

The news suggests recent volatility and potential significant events affecting the stock. Investors should closely monitor news and company announcements.

### 5. Recent Earnings Analysis

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-05-09 | 0.03   | 0.12 B$    |
| 2024-11-07 | 0.03   | 0.08 B$    |
| 2024-08-09 | 0.05   | 0.07 B$    |
| 2024-05-06 | -0.07  | 0.06 B$    |
| 2025-05-09 | -0.07  | 0.06 B$    |

**Analysis:**
* 변동성: earnings per share (EPS)의 변동성은 2024년 5월 -0.07에서 2025년 5월 0.03으로 꽤 변동성이 큰 수익 변화를 보였다.
* 수익 성장: 매출은 꾸준히 증가하는 추세이다.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-03-31   | $0.12B  | 87.14%        |
| 2024-12-31   | $0.11B  | 85.77%        |
| 2024-09-30   | $0.08B  | 88.86%        |
| 2024-06-30   | $0.07B  | 88.70%        |
| 2024-03-31   | $0.06B  | 91.43%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE    |
|--------------|---------|--------|
| 2025-03-31   | $0.24B  | 2.13%  |
| 2024-12-31   | $0.22B  | 10.49% |
| 2024-09-30   | $0.19B  | 2.02%  |
| 2024-06-30   | $0.18B  | 3.87%  |
| 2024-03-31   | $0.16B  | -6.69% |

**Analysis:**

*   **Increasing Revenue:** Revenue has generally increased over the past five quarters.
*   **High Profit Margins:** Profit margins are consistently high, indicating strong cost control or pricing power.
*   **Equity Growth:** Equity has been growing, suggesting successful capital management.
*   **Variable ROE:** Return on Equity (ROE) is variable, with a negative value in Q1 2024 and a high value in Q4 2024, indicating inconsistent profitability relative to equity.

### 7. 종합분석 (Overall Analysis)

TGTX is experiencing a challenging period. While revenue is growing and profit margins are strong, the stock is underperforming the S&P 500. The recent stock price is trending downward, the hybrid signal suggests a cautious approach. The deeply negative expected return is a major concern. Recent news suggests the company is undergoing significant changes.

**Conclusion:**

Based on the data provided, a cautious approach to TGTX is warranted. While positive aspects like revenue growth and high profit margins exist, the negative expected return, recent underperformance, and significant volatility necessitate careful monitoring of company news and developments. The recommendation is to reduce holdings and hold cash until a clearer positive outlook emerges.
